Keymed Biosciences Inc. (HKG:2162)
54.55
-1.20 (-2.15%)
At close: Feb 13, 2026
67.85% (1Y)
| Market Cap | 16.07B +96.3% |
| Revenue (ttm) | 955.73M +968.2% |
| Net Income | -281.99M |
| EPS | -1.07 |
| Shares Out | 294.60M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 774,000 |
| Average Volume | 1,180,922 |
| Open | 55.60 |
| Previous Close | 55.75 |
| Day's Range | 54.50 - 56.15 |
| 52-Week Range | 31.80 - 80.00 |
| Beta | -0.08 |
| RSI | 42.29 |
| Earnings Date | Mar 27, 2026 |